Synspira’s PAAG15A receives orphan drug designation for cystic fibrosis treatment

pharmanewsdaily- October 14, 2018 0

Synspira Therapeutics’ investigational inhaled treatment, PAAG15A, has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of cystic ... Read More